IRCT201403041774N6已完成2 期
comparison of the effect of insulin glargine on glycemic control when combined with either metformin or acarbose in Type 2 diabetic patients
Physiology research center, Vice chancellor for Research and Technology of kerman medical University0 个研究点目标入组 152 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 152
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •1. Type 2 diabetes (based on American Diabetes Association criteria)
- •2. age group 18-75 years
- •3. Enough acuity and alertness to injection of insulin
- •4. no glycemic control with oral medications
- •Exclusion criteria:
- •1. Chronic Complications of Diabetes
- •2. Pregnancy
- •3. Breastfeeding
- •4. Liver Disease
- •5. kidney disease
- •6. neurological disease
- •7. chronic inflammatory disease
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Impact of Insulin Glargine compared to Insulin Detemir in combination with Metformin (BOT) on prandial beta cell function and overall metabolic control in type 2 diabetic patients with insufficient metabolic control during OAD Treatment - Insulin glargine and prandial beta cell functionDiabetes mellitus Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006109-26-DEInstitut für Klinische Forschung und Entwicklung (ikfe) GmbH
招募中
不适用
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30
尚未招募
不适用
Comparison study between insulin glargine and decludec on the glucose fluctuation in Type 2 diabetic patients treated with basal insulin and oral hypoglycemic agents.JPRN-UMIN000012138Kyorin University of Medicine30
进行中（未招募）
1 期
Efecto de la insulina glulisina en comparación con la insulina aspart y la insulina lispro cuando se administran mediante Infusión Subcutánea Continua de Insulina (ISCI) sobre parámetros específicos de la bomba en pacientes con Diabetes Mellitus de tipo 1 - Estudio de bombasEUCTR2007-003579-38-ESsanofi-aventis groupe270
招募中
不适用
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000043068Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine30